Margaret Karugia, | |
705 Castlewood Pl, Upper Marlboro, MD 20774-6006 | |
(443) 223-0623 | |
Not Available |
Full Name | Margaret Karugia |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 705 Castlewood Pl, Upper Marlboro, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205224706 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | LPN1005583 (District Of Columbia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Margaret Karugia, 705 Castlewood Pl, Upper Marlboro, MD 20774-6006 Ph: (443) 223-0623 | Margaret Karugia, 705 Castlewood Pl, Upper Marlboro, MD 20774-6006 Ph: (443) 223-0623 |
News Archive
University of Michigan researchers have identified the first biomarker of graft-versus-host disease of the skin. The discovery makes possible a simple blood test that should solve a treatment dilemma facing doctors with patients who frequently develop rashes after bone marrow transplants.
Hemimegalencephaly is a rare but dramatic condition in which the brain grows asymmetrically, with one hemisphere becoming massively enlarged. Though frequently diagnosed in children with severe epilepsy, the cause of hemimegalencephaly is unknown and current treatment is radical: surgical removal of some or all of the diseased half of the brain.
While the number of men dying from a heart attack has been constantly decreasing during the past twenty years, the fatal risk particularly in young women has increased significantly. Gender medicine has already demonstrated that women exhibit different symptoms. A new insight shows that stress in the daily routine has particularly adverse effects on the hearts of women. This was emphasised by Alexandra Kautzky-Willer, Professor for Gender Medicine of MedUni Vienna, on the occasion of the impending International Women's Day on 8 March 2016.
EntreMed, Inc., today announced the publication of preclinical data for its Phase 2 oncology drug candidate, ENMD-2076 an Aurora A/angiogenic kinase inhibitor, which demonstrated significant activity against multiple myeloma cell lines and in MM models in vivo. Results of the study, conducted by EntreMed's collaborator, Sherif Farag, M.D., Ph.D., and colleagues at the Indiana University School of Medicine, were published in the on-line version of the British Journal of Haematology on June 15, 2010 and are scheduled to be published in print in the August 1, 2010 issue.
› Verified 4 days ago
Hans Prince Doherty Sr., Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10203 Grandhaven Ave, Upper Marlboro, MD 20772 Phone: 443-240-7072 | |
Gladys Momoh, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 10081 Campus Way S, Upper Marlboro, MD 20774 Phone: 202-704-2920 | |
Ms. Olivia Ugochi Akas, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2103 Hancock Dr, Upper Marlboro, Upper Marlboro, MD 20774 Phone: 301-273-8468 | |
Ngozi Akas, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 2103 Hancock Dr, Upper Marlboro, MD 20774 Phone: 240-543-1648 | |
Miss Queen U Nzeh, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4317 Reverend Eversfield Ct, Upper Marlboro, MD 20772 Phone: 973-687-5209 | |
Dorothy I Felix, CPR INSTRUCTOR Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 14700 Elberfeld Ct, Upper Marlboro, MD 20774 Phone: 240-521-9180 |